Fate Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2020: 0.02x

Fate Therapeutics Inc capital reinvestment ratio. Fate Therapeutics Inc (FATE) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($38.84 Million) in capital expenditures ($636.00K). Check FATE cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$38.84 Million

USD

Capital Expenditures

$636.00K

USD

Data as of

Jun 2020

Most recent filing

Fate Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Fate Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of Fate Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow